Tomasz Cichoń

1.8k total citations · 1 hit paper
58 papers, 1.4k citations indexed

About

Tomasz Cichoń is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Tomasz Cichoń has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Immunology and 16 papers in Oncology. Recurrent topics in Tomasz Cichoń's work include Immune cells in cancer (8 papers), Angiogenesis and VEGF in Cancer (7 papers) and Mesenchymal stem cell research (7 papers). Tomasz Cichoń is often cited by papers focused on Immune cells in cancer (8 papers), Angiogenesis and VEGF in Cancer (7 papers) and Mesenchymal stem cell research (7 papers). Tomasz Cichoń collaborates with scholars based in Poland, United States and France. Tomasz Cichoń's co-authors include Ryszard Smolarczyk, Magdalena Jarosz–Biej, Stanisław Szala, Justyna Czapla, Sybilla Matuszczak, Aleksander Sochanik, Iwona Mitrus, Józef Dulak, Bożena Lackowska and Claudine Kiéda and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Tomasz Cichoń

55 papers receiving 1.4k citations

Hit Papers

Tumor Microenvironment as A “Game Changer” in Cancer Radi... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Cichoń Poland 19 698 378 348 221 209 58 1.4k
Ryszard Smolarczyk Poland 18 647 0.9× 373 1.0× 340 1.0× 214 1.0× 198 0.9× 48 1.4k
Yan Fan China 20 695 1.0× 453 1.2× 353 1.0× 304 1.4× 131 0.6× 67 1.5k
Sang‐Yeob Kim South Korea 24 797 1.1× 440 1.2× 271 0.8× 262 1.2× 266 1.3× 81 1.6k
Yingqi Zhang China 28 1.3k 1.9× 471 1.2× 425 1.2× 482 2.2× 199 1.0× 127 2.8k
Ranjini K. Sundaram United States 20 557 0.8× 369 1.0× 274 0.8× 165 0.7× 64 0.3× 45 1.4k
Yuhua Li China 24 861 1.2× 641 1.7× 244 0.7× 367 1.7× 159 0.8× 88 1.7k
Yao Yuan China 20 855 1.2× 500 1.3× 174 0.5× 376 1.7× 170 0.8× 72 1.6k
Laëtitia Delort France 24 627 0.9× 470 1.2× 148 0.4× 300 1.4× 239 1.1× 45 1.6k
Sanam Sadreddini Iran 16 734 1.1× 281 0.7× 265 0.8× 366 1.7× 138 0.7× 25 1.4k
Shuli Zhao China 27 1.1k 1.6× 489 1.3× 723 2.1× 484 2.2× 107 0.5× 78 2.1k

Countries citing papers authored by Tomasz Cichoń

Since Specialization
Citations

This map shows the geographic impact of Tomasz Cichoń's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Cichoń with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Cichoń more than expected).

Fields of papers citing papers by Tomasz Cichoń

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Cichoń. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Cichoń. The network helps show where Tomasz Cichoń may publish in the future.

Co-authorship network of co-authors of Tomasz Cichoń

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Cichoń. A scholar is included among the top collaborators of Tomasz Cichoń based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Cichoń. Tomasz Cichoń is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Czapla, Justyna, Ryszard Smolarczyk, Sybilla Matuszczak, et al.. (2024). The comparison of adipose-derived stromal cells (ADSCs) delivery method in a murine model of hindlimb ischemia. Stem Cell Research & Therapy. 15(1). 27–27. 1 indexed citations
4.
Cichoń, Tomasz, et al.. (2024). Metabolomic Analysis of Histological Composition Variability of High-Grade Serous Ovarian Cancer Using 1H HR MAS NMR Spectroscopy. International Journal of Molecular Sciences. 25(20). 10903–10903. 1 indexed citations
5.
Czapla, Justyna, Sybilla Matuszczak, Tomasz Cichoń, et al.. (2023). Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context. Frontiers in Oncology. 13. 1249524–1249524. 11 indexed citations
7.
Czapla, Justyna, et al.. (2022). The Complex Composition of Trans-resveratrol, Quercetin, Vitamin E and Selenium Inhibits the Growth of Colorectal Carcinoma. Anticancer Research. 42(10). 4763–4772. 4 indexed citations
8.
Cichoń, Tomasz, Justyna Czapla, Magdalena Jarosz–Biej, et al.. (2021). The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers. 13(16). 3924–3924. 13 indexed citations
9.
Hrdinka, Matouš, Ryszard Smolarczyk, Tomasz Cichoń, et al.. (2021). Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment. Cells. 10(5). 967–967. 12 indexed citations
10.
Jaworska, Joanna, Ryszard Smolarczyk, Monika Musiał‐Kulik, et al.. (2021). Electrospun paclitaxel delivery system based on PGCL/PLGA in local therapy combined with brachytherapy. International Journal of Pharmaceutics. 602. 120596–120596. 16 indexed citations
11.
Jarosz–Biej, Magdalena, Ryszard Smolarczyk, Tomasz Cichoń, et al.. (2020). Brachytherapy in a Single Dose of 10Gy as an “in situ” Vaccination. International Journal of Molecular Sciences. 21(13). 4585–4585. 14 indexed citations
12.
Waś, Halina, Tomasz Cichoń, Ryszard Smolarczyk, et al.. (2020). Effect of Heme Oxygenase-1 on Melanoma Development in Mice—Role of Tumor-Infiltrating Immune Cells. Antioxidants. 9(12). 1223–1223. 12 indexed citations
13.
Jarosz–Biej, Magdalena, et al.. (2019). Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy. International Journal of Molecular Sciences. 20(13). 3212–3212. 378 indexed citations breakdown →
14.
Czapla, Justyna, Sybilla Matuszczak, Ewa Wiśniewska, et al.. (2016). Human Cardiac Mesenchymal Stromal Cells with CD105+CD34- Phenotype Enhance the Function of Post-Infarction Heart in Mice. PLoS ONE. 11(7). e0158745–e0158745. 26 indexed citations
15.
Cichoń, Tomasz, et al.. (2014). D-K6L9 Peptide Combination with IL-12 Inhibits the Recurrence of Tumors in Mice. Archivum Immunologiae et Therapiae Experimentalis. 62(4). 341–351. 19 indexed citations
16.
Mitrus, Iwona, Tomasz Cichoń, Ryszard Smolarczyk, et al.. (2013). Antitumor Effects of Recombinant Antivascular Protein ABRaA-VEGF121 Combined with IL-12 Gene Therapy. Archivum Immunologiae et Therapiae Experimentalis. 62(2). 161–168. 8 indexed citations
17.
Sochanik, Aleksander, Iwona Mitrus, Ryszard Smolarczyk, et al.. (2010). Experimental Anticancer Therapy with Vascular-disruptive Peptide and Liposome-entrapped Chemotherapeutic Agent. Archivum Immunologiae et Therapiae Experimentalis. 58(3). 235–245. 5 indexed citations
18.
Cichoń, Tomasz, et al.. (2009). Oxidation of carbidopa by tyrosinase and its effect on murine melanoma. Bioorganic & Medicinal Chemistry Letters. 19(13). 3507–3510. 5 indexed citations
19.
Waś, Halina, Tomasz Cichoń, Ryszard Smolarczyk, et al.. (2006). Overexpression of Heme Oxygenase-1 in Murine Melanoma. American Journal Of Pathology. 169(6). 2181–2198. 167 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026